Share

Centivax CEO discusses President Trump's multiple Covid-19 treatments

Jacob Glanville, founder and CEO of Centivax, which is developing its own monoclonal antibody to treat Covid-19 patients, joins 'Closing Bell' to talk about the effectiveness and cost of multiple Covid-19 treatments.
05:36
Mon, Oct 5 20204:27 PM EDT